GNGeraldo Santana Xavier Nunes Neto

Geraldo Santana Xavier Nunes Neto

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Geraldo Santana Xavier Nunes Neto has a total of 11 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Acidente vascular cerebral: Explorando a fisiopatologia e distúrbios do sono

    by Rafael Monteiro de Paula, Humberto Cavalcante Hourani, Gil Guimarães Barbosa Trivelli, Omar Karajah, Geraldo Santana Xavier Nunes Neto, Melissa Martins Gontijo Aires

    Cerebrovascular accident (CVA) is characterized by a focal neurological deficit resulting from brain damage of an ischemic or hemorrhagic nature. The objective of this work is to address the pathophysiology of the disease, describing clinical manifestations in patients with a previous history of stroke, in addition to establishing a correlation with sleep disorders. The present study is an integrative review of the literature, of a descriptive nature, which established that the main risk factors for the development of the disease are: hypertension, smoking, alcoholism and atrial fibrillation. The most common involvement is the ischemic type, representing 80% of cases, occurring mainly in adult and elderly patients, with a higher incidence after the age of 65, doubling every decade after the age of 55. The diagnosis is clinical, with findings of numbness of the face and limbs, mental confusion, imbalance and gait changes. Treatment involves thrombolysis and thrombectomy, both guided by neuroimaging. Added to this, there is an intimate relationship between the disease and sleep disorders, including parasomnias, insomnia and hypersomnia. Furthermore, post-stroke sleep disorders affect rehabilitation and quality of life, increasing the recurrence rate of this pathology.


  • Open Access

    COVID-19: Aspectos gerais e impactos na saúde dos idosos

    by Rafael Monteiro de Paula, Humberto Cavalcante Hourani, Gil Guimarães Barbosa Trivelli, Omar Karajah, Geraldo Santana Xavier Nunes Neto, Melissa Martins Gontijo Aires

    A COVID-19 caracteriza-se por ser uma infecção viral das vias aéreas que afeta principalmente as células epiteliais/alveolares e endoteliais, resultando na descamação de pneumócitos, presença de membrana hialina, formação e inflamação intersticial com infiltração de linfócitos, podendo evoluir com desfechos graves, como pneumonia, coagulação intravascular disseminada (CIVD) e insuficiência de múltiplos órgãos. O objetivo do trabalho é elucidar a fisiopatologia da COVID-19, discutir métodos diagnósticos, enumerar os principais sintomas e formas de tratamento. Além disso, abordar os impactos na população idosa, já que as maiores taxas de óbito ocorrem nessa população. Para tanto, foi realizada uma revisão integrativa da literatura, de caráter descritivo. Em relação ao diagnóstico da COVID-19 pode ser realizado a partir de método clínico, clínico-epidemiológico, clínico-imagem e laboratorial. As complicações da COVID-19 acometem principalmente indivíduos que se encaixam nos fatores de risco: idosos, tabagistas, hipertensos, diabéticos, obesos e imunodeficientes. Alguns estudos indicaram que quase a metade dos óbitos por COVID - 19 ocorreram entre os idosos institucionalizados e que mais de 100 mil idosos foram fatalmente atingidos no País, além de ter aumento de morbimortalidade naqueles que fazem uso de IECA ou ARA-II e, em geral, essa população apresentava como sintomas mais frequentes febre, tosse e dispneia, mas apresentam maior fragilidade por serem mais suscetíveis a infecções, devido à imunossenescência. Ademais, várias são as drogas em avaliação para o manejo da COVID, a exemplo dos antivirais, anticorpos, agentes anti-inflamatórios, imunomoduladores, anticoagulantes e antifibrinolítico.

  • Open Access

    Interstitial duplication syndrome in the chromosomic region 15q11q13: a case report

    by Thaís Ribeiro Garcia, Miguel Carlos Azevedo Cruz, Geraldo Santana Xavier Nunes Neto, Eduarda Pereira Castanheira, Paôlla Nayme Martins Morais Nicolau, Eduardo Francisco Cardoso, Thaís Bomfim Teixeira

    Introduction: The chromosomal region 15q11-13 contains a group of genes essential for normal neurodevelopment and alterations in this region result in different syndromes. Among the most frequent alterations, there are chromosomal deletions and duplications. Duplications of chromosome region 15q11q13 occur as a supernumerary chromosome 15, and may occur as interstitial duplications. The main clinical manifestations are intellectual impairment, problems with vision, hearing, teething and in bones and joints. Currently, there are few cases reported in the literature about this genetic condition, which justifies the relevance of this study. Objective: To report a case of duplication in the chromosomal region 15q11q13 and describe the clinical manifestations. Methodology: This is a case report of a qualitative nature. Case report: J.V.A.S., male, eight years old, attended at the Associação de Pais e Amigos dos Excepcionais (APAE), in Anápolis, Goiás, Brazil, in 2017, diagnosed with neuropsychomotor developmental delay (ADNPM) and macrocrania. No complications during childbirth. The patient had head support at six months, sat up at nine months, walked and talked at one year and ten months. He attends school and has good interaction, but has learning difficulties. In 2018, the CGH – ARRAY (aCGH) revealed the presence of a duplication in 15q11.2q13.1 of approximately 6.1Mb classified as pathogenic. Results and discussion: Due to the rarity of this syndrome, we did not find a satisfactory number of articles that specifically addressed this duplication. Conclusion: It is necessary to carry out more studies, in the long term and through satisfactory samples, in order to elucidate the main aspects involved in this pathology.